ATE143024T1 - Aminoacyl und oligopeptidylderivate von allopurinol mit immunostimulierender wirkung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Aminoacyl und oligopeptidylderivate von allopurinol mit immunostimulierender wirkung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number: ATE143024T1
Authority: AT; Austria
Prior art keywords: oligopeptidyl; allopurinol; aminoacyl; derivatives; pharmaceutical preparations
Prior art date: 1991-03-22

Application number

AT92830136T

Other languages

English (en)

Inventor

Mauro Marzi

Patrizia Minetti

Piero Foresta

Maria Ornella Tinti

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-22

Filing date

1992-03-20

Publication date

1996-10-15

1992-03-20 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

1996-10-15 Application granted granted Critical

1996-10-15 Publication of ATE143024T1 publication Critical patent/ATE143024T1/de

Links

OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical class OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 title abstract 3
230000003308 immunostimulating effect Effects 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 abstract 2
SHAVAUDERMUSPN-DVRYWGNFSA-N (2s)-2,6-diamino-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-3-(4h-imidazol-4-yl)-1-oxopropan-2-yl]hexanamide Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(N)=O)CC1C=NC=N1 SHAVAUDERMUSPN-DVRYWGNFSA-N 0.000 abstract 1
AFLBTVGQCQLOFJ-UHFFFAOYSA-N 2-[[1-(2,6-diaminohexanoyl)pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NCCCCC(N)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O AFLBTVGQCQLOFJ-UHFFFAOYSA-N 0.000 abstract 1
NTUPOKHATNSWCY-UHFFFAOYSA-N 2-[[1-(2-amino-3-phenylpropanoyl)pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C1CCC(C(=O)NC(CCCN=C(N)N)C(O)=O)N1C(=O)C(N)CC1=CC=CC=C1 NTUPOKHATNSWCY-UHFFFAOYSA-N 0.000 abstract 1
UZFHNLYQWMGUHU-UHFFFAOYSA-N 2-[[6-amino-2-[(2-amino-3-carboxypropanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)CC(N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(O)=O UZFHNLYQWMGUHU-UHFFFAOYSA-N 0.000 abstract 1
JLMZKEQFMVORMA-UHFFFAOYSA-N 5-(diaminomethylideneamino)-2-[[1-(pyrrolidine-2-carbonyl)pyrrolidine-2-carbonyl]amino]pentanoic acid Chemical compound NC(N)=NCCCC(C(O)=O)NC(=O)C1CCCN1C(=O)C1NCCC1 JLMZKEQFMVORMA-UHFFFAOYSA-N 0.000 abstract 1
239000004475 Arginine Substances 0.000 abstract 1
PSZNHSNIGMJYOZ-UHFFFAOYSA-N Aspartyl-Arginine Chemical compound OC(=O)CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N PSZNHSNIGMJYOZ-UHFFFAOYSA-N 0.000 abstract 1
108010016626 Dipeptides Proteins 0.000 abstract 1
SCCPDJAQCXWPTF-UHFFFAOYSA-N Glycyl-Aspartate Chemical compound NCC(=O)NC(C(O)=O)CC(O)=O SCCPDJAQCXWPTF-UHFFFAOYSA-N 0.000 abstract 1
108010008488 Glycylglycine Proteins 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
SENJXOPIZNYLHU-IUCAKERBSA-N Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-IUCAKERBSA-N 0.000 abstract 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 abstract 1
CXISPYVYMQWFLE-UHFFFAOYSA-N alanylglycine Chemical compound CC(N)C(=O)NCC(O)=O CXISPYVYMQWFLE-UHFFFAOYSA-N 0.000 abstract 1
108010047495 alanylglycine Proteins 0.000 abstract 1
125000000266 alpha-aminoacyl group Chemical group 0.000 abstract 1
235000001014 amino acid Nutrition 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
235000003704 aspartic acid Nutrition 0.000 abstract 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
108010026970 bursopoietin Proteins 0.000 abstract 1
150000001768 cations Chemical class 0.000 abstract 1
229940043257 glycylglycine Drugs 0.000 abstract 1
108010000761 leucylarginine Proteins 0.000 abstract 1
108010089198 phenylalanyl-prolyl-arginine Proteins 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
108010001055 thymocartin Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT92830136T 1991-03-22 1992-03-20 Aminoacyl und oligopeptidylderivate von allopurinol mit immunostimulierender wirkung und diese enthaltende pharmazeutische zubereitungen ATE143024T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITRM910189A IT1244501B (it)	1991-03-22	1991-03-22	Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number	Publication Date
ATE143024T1 true ATE143024T1 (de)	1996-10-15

Family

ID=11399991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92830136T ATE143024T1 (de)	1991-03-22	1992-03-20	Aminoacyl und oligopeptidylderivate von allopurinol mit immunostimulierender wirkung und diese enthaltende pharmazeutische zubereitungen

Country Status (9)

Country	Link
US (1)	US5272151A (de)
EP (1)	EP0506628B1 (de)
JP (1)	JP3067886B2 (de)
AT (1)	ATE143024T1 (de)
DE (1)	DE69213794T2 (de)
DK (1)	DK0506628T3 (de)
ES (1)	ES2094335T3 (de)
GR (1)	GR3021556T3 (de)
IT (1)	IT1244501B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5928191A (en) *	1993-07-30	1999-07-27	E.P. Technologies, Inc.	Variable curve electrophysiology catheter
US6110923A (en) *	1994-06-22	2000-08-29	Biochem Pharma Inc.	Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity
AU1520699A (en)	1997-11-07	1999-05-31	Johns Hopkins University, The	Methods for treatment of disorders of cardiac contractility
CA2340214C (en)	1998-08-12	2007-10-30	Triangle Pharmaceuticals, Inc.	Method of manufacture of 1,3-oxathiolane nucleosides
ATE383355T1 (de) *	2001-03-01	2008-01-15	Abbott Lab	Polymorph und andere kristallinische formen von zusammen-ftc
WO2003051298A2 (en) *	2001-12-14	2003-06-26	Pharmasset Ltd.	Preparation of intermediates useful in the synthesis of antiviral nucleosides
MXPA05001451A (es)	2002-08-06	2005-09-30	Pharmasset Ltd	Procesos para preparar nucleosidos de 1,3-dioxolano.
US6953041B2 (en) *	2002-10-09	2005-10-11	Micell Technologies, Inc.	Compositions of transition metal species in dense phase carbon dioxide and methods of use thereof
WO2005066694A2 (en) *	2003-12-29	2005-07-21	Advanced Medical Optics, Inc.	Intraocular lenses having a visible light-selective-transmissive-region
US7067659B2 (en) *	2004-04-23	2006-06-27	Duke University	Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof
CA2564921C (en)	2004-04-30	2015-03-24	Advanced Medical Optics, Inc.	Ophthalmic devices having a highly selective violet light transmissive filter and related methods
AU2005309835B2 (en) *	2004-11-22	2011-08-04	Johnson & Johnson Surgical Vision, Inc.	Copolymerizable azo compounds and articles containing them
ATE525664T1 (de)	2004-11-22	2011-10-15	Abbott Medical Optics Inc	Copolymerisierbare methin- und anthrachinon- verbindungen und artikel damit
US8188098B2 (en) *	2008-05-19	2012-05-29	Hoffmann-La Roche Inc.	GPR119 receptor agonists
US11406713B2 (en) *	2013-03-15	2022-08-09	Xortx Therapeutics, Inc.	Xanthine oxidase inhibitor formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3165520A (en) *		1965-01-12		Certificate of correction
AU564576B2 (en) *	1981-09-24	1987-08-20	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Purine derivatives
US4602089A (en) *	1982-03-12	1986-07-22	Newport Pharmaceuticals, Inc.	Process for preparing purine compounds
DK302883D0 (da) *	1983-06-30	1983-06-30	Hans Bundgaard	Allopurinol prodrugs
US4663326A (en) *	1985-04-04	1987-05-05	Warner-Lambert Company	Pyrazolo[4,3-d]pyrimidine-5,7-(4H,6H)dione or -5-thione-7-one analogs
AU611648B2 (en) *	1986-08-11	1991-06-20	Baxter International Inc.	Pivot pin bearing/seal with loose eyelet especially suited for disposable continuous flow blood filtration system cartridges
IT1213495B (it) *	1986-09-17	1989-12-20	Sigma Tau Ind Farmaceuti	Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina

1991
- 1991-03-22 IT ITRM910189A patent/IT1244501B/it active IP Right Grant
1992
- 1992-03-20 US US07/854,916 patent/US5272151A/en not_active Expired - Fee Related
- 1992-03-20 EP EP92830136A patent/EP0506628B1/de not_active Expired - Lifetime
- 1992-03-20 AT AT92830136T patent/ATE143024T1/de not_active IP Right Cessation
- 1992-03-20 ES ES92830136T patent/ES2094335T3/es not_active Expired - Lifetime
- 1992-03-20 DK DK92830136.5T patent/DK0506628T3/da active
- 1992-03-20 DE DE69213794T patent/DE69213794T2/de not_active Expired - Fee Related
- 1992-03-23 JP JP4065009A patent/JP3067886B2/ja not_active Expired - Fee Related
1996
- 1996-11-06 GR GR960402931T patent/GR3021556T3/el unknown

Also Published As

Publication number	Publication date
GR3021556T3 (en)	1997-02-28
EP0506628B1 (de)	1996-09-18
HK1006462A1 (en)	1999-02-26
DE69213794D1 (de)	1996-10-24
EP0506628A3 (de)	1992-10-21
JP3067886B2 (ja)	2000-07-24
ITRM910189A1 (it)	1992-09-22
US5272151A (en)	1993-12-21
EP0506628A2 (de)	1992-09-30
JPH05117275A (ja)	1993-05-14
ES2094335T3 (es)	1997-01-16
IT1244501B (it)	1994-07-15
ITRM910189A0 (it)	1991-03-22
DE69213794T2 (de)	1997-02-06
DK0506628T3 (da)	1996-11-11

Legal Events

Date	Code	Title	Description
1997-04-15	UEP	Publication of translation of european patent specification
2004-12-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69213794D1 (de)	1996-10-24	Aminoacyl und Oligopeptidylderivate von Allopurinol mit immunostimulierender Wirkung und diese enthaltende pharmazeutische Zubereitungen
DK0689592T3 (da)	2000-10-16	Stabile produkter af det baktericide/permeabilitetsforøgende protein og farmaceutiske sammensætninger, der indeholder disse
TW377350B (en)	1999-12-21	Peptidic ketones as interleukin-1beta-converting enzyme inhibitors
EP0254080A3 (en)	1989-05-31	Malonic acid derivatives and methods for their synthesis
NO911787D0 (no)	1991-05-07	Peptidaminer samt fremgangsmaate for fremstilling derav.
RU94015842A (ru)	1996-01-10	Пептидные кетоны, фармацевтическая композиция и способ ингибирования интерлейкин-1 протеазы
EP0573551A4 (en)	1994-06-08	Serine-rich peptide linkers
EP1323730A4 (de)	2005-01-05	Neue polypeptide und anti-hiv-arzneimittel, die diese enthalten
DK0437563T3 (da)	1995-05-29	Bioligiske aktive lægemiddelpolymerderivater
AU2001231881A1 (en)	2001-07-24	Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and theuse thereof in the synthesis of synthetic proteins and polypeptides
WO2001027136A3 (fr)	2001-12-13	Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
ATE124955T1 (de)	1995-07-15	Substrat-peptide.
DE3782880D1 (de)	1993-01-14	Hemmende peptide.
DE69002881D1 (de)	1993-09-30	Peptide und deren Benutzung.
ATE166063T1 (de)	1998-05-15	Mit ipoxantin ausgestattete oligopeptidderivate mit immunomodulatorischer wirksamkeit und diese enthaltende pharmazeutische zusammensetzungen
ATE46173T1 (de)	1989-09-15	Pharmakologisch aktive peptide.
DE453719T1 (de)	1992-04-30	Bakteriozin-peptid.
EP1221964A4 (de)	2004-12-15	Antigene modifikation von polypeptiden
ES2052447A1 (es)	1994-07-01	Peptidos hemorreguladores.